PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373901
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1373901
Biopreservation market size was valued at USD 2,308.6 Million in 2022, expanding at a CAGR of 30.3% from 2023 to 2030.
Biopreservation is a method that helps to maintain the functionality and integrity of biological products including tissue, stem cells, DNA, and organs under several temperatures, thereby extending their lifespan outside their natural surroundings. Biopreservation uses microorganisms and their metabolic by-products to enhance food shelf life and safety. Bio-preservation equipment and bio-preservation media are the two basic categories of bio-preservation. Bio-preservation equipment involves tools that preserve biospecimens like clinical biomarkers, bio-based therapeutics, cells, diagnostic biochips, and viruses. Various biospecimens, such as stem cells, human tissue samples, and organs are processed using it.
Biopreservation Market- Market Dynamics
The rising prevalence of chronic illnesses, the growth of biospecimen testing, and the advancement of regenerative medicine are the primary factors boosting the market growth.
The rising frequency of chronic diseases and obesity across the world is the primary trend fueling the market growth. Patients suffering from chronic diseases involving heart disease, diabetes, and degenerative illnesses affecting nerves, bones, and joints among others, are rapidly growing the biopreservation market demand. Additionally, the use of improved biospecimen preservation techniques has placed a burden on the healthcare sector due to the growing number of patients.
As a result, the extensive adoption and use of bio-preservation technology has facilitated market expansion. However, an expensive process is a major reason expected to restrain the market growth. Furthermore, biopreservation techniques are widely used to manage the efficacy and integrity of regenerative treatments as various chronic illnesses and degenerative ailments are managed and treated by regenerative medications. Thus, the rising utilization of regenerative drugs directly contributed to the growing demand for biopreservation.
Biopreservation Market- Key Insights
As per the analysis shared by our research analyst, the global biopreservation market is estimated to grow annually at a CAGR of around 30.3% over the forecast period (2023-2030)
The biopreservation industry is projected to grow at a significant rate due to the growing cases of chronic disease and obesity
Based on type segmentation, thawing equipment was predicted to show maximum market share in the year 2022
Based on end user segmentation, biobank was the leading type in 2022
The rising requirements for organ transplants, the growing demand for room temperature storage technologies, and the increasing amount of research studies in the field of biopreservation are suitable opportunities for the growth of the bio-preservation market.
The global biopreservation market is segmented on the basis of type, application, end user, and region.
The market is divided into six categories based on type: thawing equipment, bio-preservation media, biospecimen equipment, cryogenic storage systems, freezers, and refrigerators. The thawing equipment segment is expected to hold the largest revenue share over the forecast period owing to the increasing demand for bio-banking to preserve tissue culture, DNA, stem cells, and plasma. The global utilization and acceptance of preservation have benefited low maintenance and adequate storage capacity is expected to fuel the market. Moreover, the biopreservation media segment is likely to grow because it is an essential part of the biopreservation process. The segment is attributed to offer various details as well as features, allowing researchers to access and share research data thereby improving their ability to diagnose, research, treat, and monitor health disorders. Thus, this trend is projected to drive the market growth.
The market is divided into three categories based on end-users: gene banks, hospitals, biobanks, and others. The biobank segment is likely to hold the largest market share. The segment growth is attributed to the increasing acceptance of sperm and egg banking, utilizing assisted reproductive technology with animals, and raising awareness for stem cell preservation. Additionally, the pharmaceutical sector has collaborations with tissue preservation and reserve bio-banks with hospitals.
Biopreservation Market- Geographical Insights
North America is witnessing dominance in the biopreservation market due to the steady drug expansions and the advent of advanced therapies in the biomedical research field. Additionally, for chronic diseases, the considerable increase in the patient base requiring high-end treatment is also expecting a high demand for bio-preservation services and products which will fuel the growth of the bio-preservation market. Moreover, Asia Pacific is likely to observe significant growth in the bio-preservation market during the forecast period due to the steady increase in the number of patients suffering from chronic diseases. In line with this, in research and development, the growing government investments are enhancing the possibility for the acceptance of bio-storage which is resulting in stimulating the bio-preservation market.
Private and public organizations have made major investments in R&D efforts connected to the creation of new medications, which will help in treating the rising number of chronic diseases. The increase in expenditure is intended to provide access to advanced products and superior medical care, such as biopreservation facilities. Additionally, governments across the world are adopting various steps to enhance cell therapies for the treatment of different diseases. Moreover, market players are increasingly focusing on adopting lucrative strategies such as mergers & acquisitions, collaboration, new partnerships, and product launches to gain a competitive edge in the market. For instance, in January 2022, BioLife Solutions, Inc. announced an extended collaboration with Seattle Children's Therapeutics, a venture at Seattle Children's, bringing cutting-edge, curative technologies and therapies to fight against pediatric cancer and other diseases that impact children. The collaboration will focus on establishing improved practices in biopreservation and closed-system manufacturing with the integration and introduction of Sexton's AF-500™ for closed-system processing for cell therapy manufacturing and viral vector delivery that will be utilized in Seattle Children's Therapeutics new lentiviral vector manufacturing facility called VectorWorks.
For instance, in January 2023, the Tissue Biobank Service was introduced in Qatar, through collaboration between the Department of Laboratory Medicine and Pathology (DLMP) at Hamad Medical Corporation (HMC) and Qatar BioBank (QBB). Tissue biobanking is the method of processing, collecting, distributing, and storing human tissue samples for research purposes. These tissue samples are acquired from surplus tissue after surgical procedures or biopsies, and they are employed to study a wide range of health conditions and diseases.